Articles From: Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease to American Apparel Appoints Colleen B. Brown as Chairperson of the Board of Directors


Baxter International Inc. (NYSE:BAX) today announced that the company has submitted a biologics license application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for the approval of BAX111, the first highly-purified recombinant von Willebrand Factor (rVWF) in clinical development as a treatment for patients with von Willebrand disease, the most common type of inherited bleeding disorder.
Sign-up for Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease investment picks
TEL AVIV, Israel, Dec.
Sign-up for RiT Technologies Promotes Eran Erov to VP Finance investment picks
2014/12/22
To Win This "Small Business in a Box" Just Follow @HolidayInn and Tweet #SmallBizWishContest ATLANTA , Dec.
Sign-up for Holiday Inn® Brand Wants To Give One Small Business The Ultimate Holiday Gift - $25,000 And Face Time With Small Business Experts From MBAs Across America investment picks
2014/12/22
By Michael Calia Oracle Corp.
Sign-up for Oracle Buys Ad-Analytics Firm Datalogix investment picks
2014/12/22
Real time visualization shows bustle of activity heading into Santa's busiest night of the year CHELMSFORD, Mass.
Sign-up for Naughty, Nice and Busy - Datawatch Visualizes Santa's Internet of Toys investment picks
Tesco Corp.
Sign-up for UPDATE: Tesco Corp. warns of profit, sales miss investment picks
2014/12/22
By Anora Mahmudova and Sara Sjolin, MarketWatch AbbVie jumps on FDA's hepatitis C drug approval NEW YORK (MarketWatch) -- U.S. stock futures were slightly higher on Monday amid some year-end deal making in a shortened Christmas week.
Sign-up for UPDATE: U.S. stocks: Futures point to higher open; existing-home sales next investment picks
LEESBURG, Va., Dec.
Sign-up for K2M Announces Completion of First Surgical Case Using CAPRI(TM) Corpectomy Cage System investment picks
2014/12/22
LONDON , Dec.
Sign-up for Noble Corporation Announces Results Of Shareholder Vote investment picks
2014/12/22
By William Watts and Joseph Adinolfi, MarketWatch Not your garden-variety black swan U.S. stocks climbed a wall of worry in 2014 underpinned by a host of nettlesome concerns at home and abroad.
Sign-up for UPDATE: Call it a gray swan: 10 risks that could upend the market in 2015 investment picks
American Apparel Inc.'s stock (APP) rallied 7.5% in premarket trade Monday, after the apparel company said it has received an "indication of interest" to acquire the company for $1.30 to $1.40 a share.
Sign-up for American Apparel received interest to acquire the company investment picks
2014/12/22
By Ian Walker LONDON--The U.K.'s Financial Reporting Council on Monday said it has launched an investigation into Tesco PLC's accounts for fiscal 2012, 2013 and 2014, following the recent accounting scandal at the supermarket chain.
Sign-up for Tesco Faces Fresh Accounting Investigation -- 2nd Update investment picks
VANCOUVER, British Columbia, Dec.
Sign-up for Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV investment picks
MARLBOROUGH, Mass.
Sign-up for Boston Scientific To Participate In 33rd Annual J.P. Morgan Healthcare Conference investment picks
2014/12/22
New Jersey American Water has provided a bit of holiday cheer to area United Way agencies in the form of a $15,000 end-of-year grant to the United Way of Greater Philadelphia and Southern New Jersey.
Sign-up for A Holiday Gift for the United Way investment picks
TerraForm Power (TERP) said it was increasing its quarterly dividend by 20% to 27 cents a share, payable March 16, 2015 to shareholders of record on March.
Sign-up for TerraForm raises dividend five months after going public investment picks
Silicom Ltd.
Sign-up for Another Design Win for Silicom’s Unique Cloud Platform Solution investment picks
Cerus Corporation (NASDAQ:CERS) announced today that its Phase 2 clinical trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated red blood cells continued to circulate 24 hours following transfusion.
Sign-up for Cerus Reports US Phase 2 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint investment picks
2014/12/22
Franchise Openings indicate Growing Market at Second Tier Cities LOS ANGELES , Dec.
Sign-up for Nova LifeStyle Announces Opening of Seven New Franchise Stores in China investment picks
CIT Group Inc. (NYSE: CIT) cit.com , a leading provider of commercial lending and leasing services, today announced that it served as Lead Arranger in a $55.5 million senior secured credit facility to T5@Portland, a subsidiary of T5 Data Centers, LLC, an owner and operator of server-ready single and multi-tenant data centers across North America.
Sign-up for CIT Serves as Lead Arranger in $55.5 Million Financing to T5@Portland investment picks
MCLEAN, Va., Dec.
Sign-up for Gladstone Investment Corporation Invests $19.6 Million in B+T Group investment picks
TEL AVIV, Israel, Dec.
Sign-up for VBL Therapeutics Announces Positive Phase 2a Data for VB-111 in Recurrent Thyroid Cancer investment picks
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Dr.
Sign-up for Simulations Plus to Present at the Sidoti & Company Emerging Growth Institutional Investor Forum on January 12, 2015 investment picks
SANTA CLARA, Calif.
Sign-up for Palo Alto Networks to Present at 17th Annual Needham Growth Conference investment picks
Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has initiated development of Liposomal Bcl-2 as a treatment for follicular lymphoma.
Sign-up for Bio-Path Holdings to Initiate Development of Liposomal Bcl-2 in Follicular Lymphoma investment picks
SOUTHLAKE, Texas , Dec.
Sign-up for Sabre Corporation elects George R. Bravante, Jr., to its Board of Directors investment picks
2014/12/22
Former Co-Chairs Allan Mayer and David Danziger to Remain on Board as Committee Chairs LOS ANGELES , Dec.
Sign-up for American Apparel Appoints Colleen B. Brown as Chairperson of the Board of Directors investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Baxter Submits Application for U.S. FDA Approval of BAX111, Investigational Recombinant Treatment for Von Willebrand Disease to American Apparel Appoints Colleen B. Brown as Chairperson of the Board of Directors
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent